Caricamento...
Teriflunomide treatment reduces B cells in patients with MS
OBJECTIVE: To study the immunomodulatory effect of teriflunomide on innate and adaptive immune cell populations through a pilot, open-label, observational study in a cohort of patients with relapsing-remitting MS. METHODS: Blood lymphocytes were isolated from 10 patients with MS before and after 3 o...
Salvato in:
| Pubblicato in: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5656406/ https://ncbi.nlm.nih.gov/pubmed/29082295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000403 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|